Trial intelligence / Profile preview

Prophylactic TCM for EGFR-TKI Related Skin Toxicity in Lung Cancer

NCT05204758Phase 3Completed

Sponsor
China Medical University Hospital
Start
May 2016
Primary completion
Dec 2017
Modality
Botanical medicine
01

Overview

A Phase 3 trial of Chi-Ju-Di-Huang-Wan + Jia-Wei-Xiao-Yao-San in acneiform eruption, sponsored by China Medical University Hospital. Started May 2016; status: completed.

02

Drugs

Chi-Ju-Di-Huang-Wan + Jia-Wei-Xiao-Yao-San
03

Conditions

acneiform eruption

Beyond the preview

Go deeper on NCT05204758.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05204758.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call